OncoDecipher
Identifying Silent Mutations for Cancer Classification and Prognosis
Startup Seed Health Tech & Life Sciences Est. 2021
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
1 rounds
Investors
1
1 public
Team
1
1-10 employees
Confidence
76/100
News
2
articles
About
OncoDecipher is developing a computational biology platform to identify silent mutations and improve pharmaceutical companies ability to identify patients who will benefit from a given treatment.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Core Technology
Platforms & InterfacesWebArtificial IntelligenceMachine Learning
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B
Tags
personalizationgenomicsartificial-intelligencemachine-learningweb-platformpredictive-analyticscancerpharma-companiesoncology
Funding & Events
Sep 2021
Seed Undisclosed
Sanara Ventures (Lead)
News (2)
Sep 1, 2021 · www.jpost.com
growth-positive
https://www.jpost.com/health-and-wellness/silent-mutations-can-predict-the-development-of-cancer-study-678299?fbclid=IwAR0DVQM0F_U3xJW9taReGbRzaydXsECch0YaRim4n6fLz47g1EzWMrGJQVo
CustomersPartners
Aug 12, 2021 · www.nature.com
Not applicable
Estimating the predictive power of silent mutations on cancer classification and prognosis - npj Genomic Medicine
Not applicable
Details
Product Stage
R&D
Employees
1-10
Exact Count
6
District
Center District
Founded
2021
Registrar
516466661
Locations
Zarhin Street 13, Ra'anana, Israel
Links
Admin
Last Update
Oct 5, 2021
Verified by
Yotam Maman
Missing
description, homepage, not claimed, video or image, markets, external profile
Team (1)
Tamir Tuller
Founder
Founder
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2021-09-22T00:00:00.000Z
Last editor
Jenny Sotnik-Talisman (genys30@yahoo.com)
Finder · OncoDecipher · 2026